ElevateBio taps Amazon's genAI tools to design CRISPR therapeutics [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
The multi-year collaboration between the two companies will see ElevateBio combine its gene editing technologies and large clustered regularly interspaced short palindromic repeats (CRISPR) dataset with AWS's advanced computing framework. US-based ElevateBio offers a range of platforms to help companies create cell and gene therapies, starting from the discovery step through to commercialisation. The company's gene editing and R&D business, ElevateBio Life Edit, includes a gene editing platform, cell and RNA engineering technologies, and a therapeutic delivery platform. Now, genAI capabilities will be added to that roster courtesy of the partnership with AWS. Its machine-learning platform SageMaker will be applied to Life Edit to enhance its prot
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Global Genome Editing Market to Grow Rapidly at a CAGR ~13% by 2032 | DelveInsight [Yahoo! Finance]Yahoo! Finance
- CRISPR Market is expected to generate a revenue of USD 12.78 Billion by 2032, Globally, at 15.85% CAGR: Verified Market Research® [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care ConferenceGlobeNewswire
- 2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 11/5/24 - Beat
CRSP
Sec Filings
- 3/18/25 - Form 4
- 3/18/25 - Form 4
- 3/18/25 - Form 4
- CRSP's page on the SEC website